1. |
|
|
2. |
|
|
3. |
|
|
4. |
|
|
5. |
|
|
6. |
|
|
7. |
- Soehnlein, O, et al.
(författare)
-
AIMing 2 treat atherosclerosis
- 2022
-
Ingår i: Nature reviews. Cardiology. - : Springer Science and Business Media LLC. - 1759-5010 .- 1759-5002. ; 19:9, s. 567-568
-
Tidskriftsartikel (refereegranskat)
|
|
8. |
|
|
9. |
|
|
10. |
- Zimmer, S, et al.
(författare)
-
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming
- 2016
-
Ingår i: Science translational medicine. - : American Association for the Advancement of Science (AAAS). - 1946-6242 .- 1946-6234. ; 8:333, s. 333ra50-
-
Tidskriftsartikel (refereegranskat)abstract
- The cyclic oligosaccharide 2-hydroxypropyl-β-cyclodextrin facilitates atheroprotective mechanisms through oxysterol-mediated reprogramming of macrophages.
|
|